Healthcare · Industry

Biotechnology - List & Prices (656 stocks)

By market cap Page 2 of 14 Prices: Sep 4, 2026 close

Biotechnology - List & Prices
#	Company	Ticker	Price	Mkt cap	P/E	Div yield
51	Travere Therapeutics, Inc.	TVTX	$65.28	$6.15B	unprofitable	—
52	Mirum Pharmaceuticals, Inc.	MIRM	$100.90	$6.15B	unprofitable	—
53	Oruka Therapeutics, Inc.	ORKA	$92.51	$6.13B	unprofitable	—
54	Terns Pharmaceuticals, Inc.	TERN	$52.95 May 15, 2026	$6.12B	unprofitable	—
55	Dianthus Therapeutics, Inc.	DNTH	$108.10	$6.05B	unprofitable	—
56	Cogent Biosciences, Inc.	COGT	$34.76	$6.03B	unprofitable	—
57	Xenon Pharmaceuticals Inc.	XENE	$59.75	$5.79B	unprofitable	—
58	PTC Therapeutics, Inc.	PTCT	$69.30	$5.78B	unprofitable	—
59	Ligand Pharmaceuticals Incorporated	LGND	$285.60	$5.69B	29.8	—
60	Erasca, Inc.	ERAS	$16.19	$5.66B	unprofitable	—
61	CRISPR Therapeutics AG	CRSP	$55.79	$5.39B	unprofitable	—
62	Apellis Pharmaceuticals, Inc.	APLS	$41.03 May 15, 2026	$5.25B	38.4	—
63	Definium Therapeutics, Inc.	DFTX	$38.09	$5.12B	unprofitable	—
64	Parabilis Medicines, Inc.	PBLS	$40.42	$4.99B	unprofitable	—
65	ACADIA Pharmaceuticals Inc.	ACAD	$28.02	$4.83B	12.6	—
66	Celcuity Inc. Common Stock	CELC	$95.70	$4.68B	unprofitable	—
67	Edgewise Therapeutics, Inc.	EWTX	$43.07	$4.68B	unprofitable	—
68	Amicus Therapeutics Inc	FOLD	$14.49 Apr 27, 2026	$4.55B	unprofitable	—
69	Dyne Therapeutics, Inc.	DYN	$24.28	$4.53B	unprofitable	—
70	Enliven Therapeutics, Inc.	ELVN	$59.32	$4.35B	unprofitable	—
71	Legend Biotech Corporation	LEGN	$21.52	$4.19B	unprofitable	—
72	Relay Therapeutics, Inc.	RLAY	$19.04	$4.17B	unprofitable	—
73	Veradermics, Incorporated	MANE	$98.51	$4.12B	unprofitable	—
74	Viking Therapeutics, Inc.	VKTX	$34.87	$4.07B	unprofitable	—
75	Telix Pharmaceuticals Limited	TLX	$11.94	$4.06B	119.4	—
76	Tarsus Pharmaceuticals, Inc.	TARS	$90.78	$3.98B	unprofitable	—
77	Iovance Biotherapeutics, Inc.	IOVA	$8.79	$3.98B	unprofitable	—
78	Catalyst Pharmaceuticals Inc	CPRX	$31.49 Jul 21, 2026	$3.85B	18.2	—
79	IDEAYA Biosciences, Inc.	IDYA	$39.86	$3.85B	unprofitable	—
80	Tango Therapeutics, Inc.	TNGX	$22.52	$3.80B	unprofitable	—
81	Arcus Biosciences, Inc.	RCUS	$29.66	$3.73B	unprofitable	—
82	AbCellera Biologics Inc.	ABCL	$11.43	$3.70B	unprofitable	—
83	Denali Therapeutics Inc. Common Stock	DNLI	$22.28	$3.56B	unprofitable	—
84	Structure Therapeutics Inc.	GPCR	$47.34	$3.38B	unprofitable	—
85	Celldex Therapeutics, Inc.	CLDX	$39.68	$3.12B	unprofitable	—
86	uniQure N.V.	QURE	$44.50	$3.09B	unprofitable	—
87	Beam Therapeutics Inc.	BEAM	$29.66	$3.06B	unprofitable	—
88	Disc Medicine, Inc.	IRON	$79.23	$3.04B	unprofitable	—
89	Immunome, Inc.	IMNM	$26.76	$3.04B	unprofitable	—
90	Arcutis Biotherapeutics, Inc.	ARQT	$23.90	$3.00B	108.6	—
91	MBX Biosciences, Inc.	MBX	$61.72	$2.97B	unprofitable	—
92	NewAmsterdam Pharma Company N.V.	NAMS	$25.40	$2.97B	unprofitable	—
93	Zai Lab Limited American Depositary Shares	ZLAB	$26.23	$2.94B	unprofitable	—
94	SELLAS Life Sciences Group, Inc.	SLS	$13.86	$2.80B	unprofitable	—
95	Soleno Therapeutics, Inc.	SLNO	$53.01 May 18, 2026	$2.76B	27.5	—
96	AtaiBeckley Inc.	ATAI	$7.39	$2.74B	unprofitable	—
97	Nurix Therapeutics, Inc.	NRIX	$26.14	$2.71B	unprofitable	—
98	Maravai LifeSciences Holdings, Inc.	MRVI	$7.32	$2.71B	unprofitable	—
99	Viridian Therapeutics, Inc.	VRDN	$22.92	$2.60B	unprofitable	—
100	Vera Therapeutics, Inc.	VERA	$35.89	$2.59B	unprofitable	—

TVTX

Travere Therapeutics, Inc.

$65.28

Healthcare / Biotechnology

Market Cap: $6.15B
P/E: unprofitable

MIRM

Mirum Pharmaceuticals, Inc.

$100.90

Healthcare / Biotechnology

Market Cap: $6.15B
P/E: unprofitable

ORKA

Oruka Therapeutics, Inc.

$92.51

Healthcare / Biotechnology

Market Cap: $6.13B
P/E: unprofitable

TERN

Terns Pharmaceuticals, Inc.

$52.95

Healthcare / Biotechnology

Market Cap: $6.12B
P/E: unprofitable

DNTH

Dianthus Therapeutics, Inc.

$108.10

Healthcare / Biotechnology

Market Cap: $6.05B
P/E: unprofitable

COGT

Cogent Biosciences, Inc.

$34.76

Healthcare / Biotechnology

Market Cap: $6.03B
P/E: unprofitable

XENE

Xenon Pharmaceuticals Inc.

$59.75

Healthcare / Biotechnology

Market Cap: $5.79B
P/E: unprofitable

PTCT

PTC Therapeutics, Inc.

$69.30

Healthcare / Biotechnology

Market Cap: $5.78B
P/E: unprofitable

LGND

Ligand Pharmaceuticals Incorporated

$285.60

Healthcare / Biotechnology

Market Cap: $5.69B
P/E: 29.8

ERAS

Erasca, Inc.

$16.19

Healthcare / Biotechnology

Market Cap: $5.66B
P/E: unprofitable

CRSP

CRISPR Therapeutics AG

$55.79

Healthcare / Biotechnology

Market Cap: $5.39B
P/E: unprofitable

APLS

Apellis Pharmaceuticals, Inc.

$41.03

Healthcare / Biotechnology

Market Cap: $5.25B
P/E: 38.4

DFTX

Definium Therapeutics, Inc.

$38.09

Healthcare / Biotechnology

Market Cap: $5.12B
P/E: unprofitable

PBLS

Parabilis Medicines, Inc.

$40.42

Healthcare / Biotechnology

Market Cap: $4.99B
P/E: unprofitable

ACAD

ACADIA Pharmaceuticals Inc.

$28.02

Healthcare / Biotechnology

Market Cap: $4.83B
P/E: 12.6

CELC

Celcuity Inc. Common Stock

$95.70

Healthcare / Biotechnology

Market Cap: $4.68B
P/E: unprofitable

EWTX

Edgewise Therapeutics, Inc.

$43.07

Healthcare / Biotechnology

Market Cap: $4.68B
P/E: unprofitable

FOLD

Amicus Therapeutics Inc

$14.49

Healthcare / Biotechnology

Market Cap: $4.55B
P/E: unprofitable

DYN

Dyne Therapeutics, Inc.

$24.28

Healthcare / Biotechnology

Market Cap: $4.53B
P/E: unprofitable

ELVN

Enliven Therapeutics, Inc.

$59.32

Healthcare / Biotechnology

Market Cap: $4.35B
P/E: unprofitable

LEGN

Legend Biotech Corporation

$21.52

Healthcare / Biotechnology

Market Cap: $4.19B
P/E: unprofitable

RLAY

Relay Therapeutics, Inc.

$19.04

Healthcare / Biotechnology

Market Cap: $4.17B
P/E: unprofitable

MANE

Veradermics, Incorporated

$98.51

Healthcare / Biotechnology

Market Cap: $4.12B
P/E: unprofitable

VKTX

Viking Therapeutics, Inc.

$34.87

Healthcare / Biotechnology

Market Cap: $4.07B
P/E: unprofitable

TLX

Telix Pharmaceuticals Limited

$11.94

Healthcare / Biotechnology

Market Cap: $4.06B
P/E: 119.4

TARS

Tarsus Pharmaceuticals, Inc.

$90.78

Healthcare / Biotechnology

Market Cap: $3.98B
P/E: unprofitable

IOVA

Iovance Biotherapeutics, Inc.

$8.79

Healthcare / Biotechnology

Market Cap: $3.98B
P/E: unprofitable

CPRX

Catalyst Pharmaceuticals Inc

$31.49

Healthcare / Biotechnology

Market Cap: $3.85B
P/E: 18.2

IDYA

IDEAYA Biosciences, Inc.

$39.86

Healthcare / Biotechnology

Market Cap: $3.85B
P/E: unprofitable

TNGX

Tango Therapeutics, Inc.

$22.52

Healthcare / Biotechnology

Market Cap: $3.80B
P/E: unprofitable

RCUS

Arcus Biosciences, Inc.

$29.66

Healthcare / Biotechnology

Market Cap: $3.73B
P/E: unprofitable

ABCL

AbCellera Biologics Inc.

$11.43

Healthcare / Biotechnology

Market Cap: $3.70B
P/E: unprofitable

DNLI

Denali Therapeutics Inc. Common Stock

$22.28

Healthcare / Biotechnology

Market Cap: $3.56B
P/E: unprofitable

GPCR

Structure Therapeutics Inc.

$47.34

Healthcare / Biotechnology

Market Cap: $3.38B
P/E: unprofitable

CLDX

Celldex Therapeutics, Inc.

$39.68

Healthcare / Biotechnology

Market Cap: $3.12B
P/E: unprofitable

QURE

uniQure N.V.

$44.50

Healthcare / Biotechnology

Market Cap: $3.09B
P/E: unprofitable

BEAM

Beam Therapeutics Inc.

$29.66

Healthcare / Biotechnology

Market Cap: $3.06B
P/E: unprofitable

IRON

Disc Medicine, Inc.

$79.23

Healthcare / Biotechnology

Market Cap: $3.04B
P/E: unprofitable

IMNM

Immunome, Inc.

$26.76

Healthcare / Biotechnology

Market Cap: $3.04B
P/E: unprofitable

ARQT

Arcutis Biotherapeutics, Inc.

$23.90

Healthcare / Biotechnology

Market Cap: $3.00B
P/E: 108.6

MBX

MBX Biosciences, Inc.

$61.72

Healthcare / Biotechnology

Market Cap: $2.97B
P/E: unprofitable

NAMS

NewAmsterdam Pharma Company N.V.

$25.40

Healthcare / Biotechnology

Market Cap: $2.97B
P/E: unprofitable

ZLAB

Zai Lab Limited American Depositary Shares

$26.23

Healthcare / Biotechnology

Market Cap: $2.94B
P/E: unprofitable

SLS

SELLAS Life Sciences Group, Inc.

$13.86

Healthcare / Biotechnology

Market Cap: $2.80B
P/E: unprofitable

SLNO

Soleno Therapeutics, Inc.

$53.01

Healthcare / Biotechnology

Market Cap: $2.76B
P/E: 27.5

ATAI

AtaiBeckley Inc.

$7.39

Healthcare / Biotechnology

Market Cap: $2.74B
P/E: unprofitable

NRIX

Nurix Therapeutics, Inc.

$26.14

Healthcare / Biotechnology

Market Cap: $2.71B
P/E: unprofitable

MRVI

Maravai LifeSciences Holdings, Inc.

$7.32

Healthcare / Biotechnology

Market Cap: $2.71B
P/E: unprofitable

VRDN

Viridian Therapeutics, Inc.

$22.92

Healthcare / Biotechnology

Market Cap: $2.60B
P/E: unprofitable

VERA

Vera Therapeutics, Inc.

$35.89

Healthcare / Biotechnology

Market Cap: $2.59B
P/E: unprofitable

Showing 51–100 of 656 · ranked by market capitalization

Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.